For Better Health
Askdocweb is about side effects
Search for
Online since 2002
Home star Site Map star Resources star Contact Us star Privacy Policy star Advertise
 

Product Recalls

Fri, 27 Aug 2010
Cal-Maine Foods, Inc. Clarifies Previous Statement on Nationwide Shell Egg Recall
Cal-Maine Foods, Inc. (NASDAQ: CALM) today issued the following clarification regarding the previously announced voluntary recall of shell eggs supplied from Hillandale Farms of Iowa. This information does not increase the total number of eggs which Cal-Maine purchased from Hillandale Farms, which was previously announced on August 20, 2010. Cal-Maine immediately contacted its customers to ensure that any eggs included in the recall were withdrawn from the marketplace.
http://www.fda.gov/Safety/Recalls/ucm224199.htm

Wed, 15 Sep 2010
Westmed, Inc. Issues Nationwide Recall of BagEasy Manual Resuscitation Devices
Westmed, Inc., Tucson, AZ, is initiating a nationwide recall of 24,384 units of BagEasy Manual Resuscitation Devices. The select lots listed below of the BagEasy device have been found to have a potential for disconnection at the retention ring of the patient port manifold.
http://www.fda.gov/Safety/Recalls/ucm225844.htm

Wed, 15 Sep 2010
Kilosports Inc. Issues Voluntary Recall of Clomed
KiloSports Inc. of Phoenix, AZ is recalling 60 Count bottles of Clomed because it may contain an Aromatase Inhibitor. KiloSports Inc. has been informed by the US Food and Drug Administration (FDA) that adverse events associated with the use of Aromatase Inhibitors could include the following: decreased rate of bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure, and liver dysfunction. Consumers who have purchased Clomed are asked to return it to the place of purchase for a full refund. Consumers with any questions may contact the company at 1.480.545.3489 9AM - 5PM Monday - Friday.
http://www.fda.gov/Safety/Recalls/ucm225847.htm

Thu, 16 Sep 2010
G.E.T. Issues Vouluntary Recall of ArimaDex
Genetic Edge Technologies of Phoenix, Arizona is voluntarily recalling 60 count bottles of ArimaDex, because it may contain an Aromatase Inhibitor. Genetic Edge Technologies has been informed by the US Food and Drug Administration (FDA) that potential adverse events associated with the use of Aromatase Inhibitors could include the following: decreased rate of bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure, and liver dysfunction.

Consumers who have purchased ArimaDex are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 1-480-248-7957 during the hours of 9AM - 2PM M-F.
http://www.fda.gov/Safety/Recalls/ucm225848.htm

Thu, 16 Sep 2010
Advanced Muscle Science Issues a Voluntary Nationwide Recall of AROM-X Capsules, AROM-X UTT Liquid, AROM-XL Liquid, 4-AD Capsules and Decavol Capsules Marketed as a Dietary Supplements Containing ATD

Advanced Muscle Science, 4590 Deodar St., Silver Springs, Nevada 89429, announced today that it is conducting a voluntary nationwide recall of all Lot Codes of the company's dietary supplement products sold under the names Arom-X, Arom-X UTT, Arom-XL, 4-AD, and Decavol, which are marketed as Natural Testosterone Boosters and Libido Enhancers. The products contain 1,4,6 etioallocholan-dione, also known as ATD, an aromatase inhibitor. These products are sold both individually and as part of promotional "Kits".

The Company is advising consumers who have Arom-X Capsules, Arom-X UTT Liquid, Arom-XL Liquid, 4-AD Capsules and Decavol Capsules to return any unused portion to the retail location from which it was purchased or if purchased directly from Advanced Muscle Science to return any unused portion to: Fitness Connection c/o AMS Fulfillment, 350 Faunce Corner Road, North Dartmouth, MA 02747; (800) 854-3891.
http://www.fda.gov/Safety/Recalls/ucm226145.htm

Thu, 16 Sep 2010
The MedWatch August 2010 Drug Safety Labeling Changes includes 24 products with safety labeling changes to the following sections: CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.
The following drugs had new or modified safety information in the CONTRAINDICATIONS and WARNINGS sections:
  • Advil Allergy Sinus (ibuprofen, chlorpheniramine maleate, and pseudoephedrine)
  • Aleve (naproxen sodium)
  • Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
  • Biltricide (praziquantel)
  • Childrens Advil Cold (ibuprofen and pseudoephedrine)
  • Cubicin (daptomycin)
  • Exelon Patch (rivastigmine)
  • Flagyl (metronidazole)
  • Heparin Sodium in the 5% Dextrose injection and in the 0.9% Sodium Chloride injection
  • Meridia (sibutramine hydrochloride)
  • Plavix (clopidogrel bisulfate)
  • Risperdal (risperidone)
The "Summary Page" provides a listing of drug names and safety labeling sections that have been revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm225299.htm

Product Recalls - 2 - 3 - 4 - Last Page 5


If you find this information useful share it with others. Use the form below to add your comments, feedback or suggestions. Please note that all addresses are held confidential.

Thanks for stopping by.
AskDocWeb

Your name:
Your email:
Share your comments in the box below:

 

This website is protected by copyright 2002-2007 Askdocweb, Inc. All Rights Reserved. This is a layman's report on recalls issued in the U.S.A. by the FDA and is not intended to replace discussions with a health care provider. Do not use the information on this forum as a substitute for your doctor's advice. Always consult your doctor before taking any drug and follow your doctor's directions. Source material: Food and Drug Administration, Medline, Physician's Desk Reference, and the largest community of people in the world, those who are concerned about side effects and healthcare.
Bottom of page